Drawing for CAREBAY

USPTO serial 99810041

CAREBAY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
CROSS, TRACY L
Law office
TMEG LAW OFFICE 109

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with CAREBAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHERYL LEE FARINE

CHERYL LEE FARINE Hudak, Shunk & Farine Co., LPA30B Northwest AvenueSuite 210Tallmadge, OH 44278

Goods and services

ClassDescriptionStatusFirst use
003Beauty masks; False eyelashes; False nails; Perfumes; Cosmetics; All-purpose cleaners; Non-medicated skin serums; Hair dyes; Body wash; Hair shampooACTIVEApr 11, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2026DOCKASSIGNED TO EXAMINER
Sep 6, 2026MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2026MAFRAPPLICATION FILING RECEIPT MAILED
May 7, 2026NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance